Vigil

Developer of therapeutic solutions for treating multiple neurodegenerative diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2020 groups56 employees language vigilneuro.com

Registered entities

Social engagement

Social engagement: 5M social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Vida Ventures, Atlas Venture, Northpond Ventures.

Investor typeCountShare
Venture capital956%
Private equity16%
Bank & private debt16%
Other / undisclosed531%
Coming soon